Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by porksnifferon Jul 22, 2021 10:37am
82 Views
Post# 33587482

RE:Glad you asked Porky ...

RE:Glad you asked Porky ...
MrMugsy wrote: Keep your numbers straight buddy.

270 people control 70% of the company.
Take those numbers to the bank.
Those were solid numbers going into 2020.

It's at that point I guess another 10% of the company is controlled by 100-150 people.

Then you've got the rest of us owning 20% of the business

---------------

That's how I know there's no way to force this one to change course.
ROW will GROW, with our without you, doncha KNOW ?
You may not like it - but - that's the way she is.

: )





Another one of your rectal plucks. The stock has been churning on high volume and shareholders are rolling over leaving this sinking ship. Where is your shareholders list? Why not show everyone your data? A few more pennies away from all time lows yet here you are cheerleading and trying to convince readers to buy in. You're a fraud, the lowest of the low. 
<< Previous
Bullboard Posts
Next >>